The DOI matches its Crossref record.
Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study
Open accessAbstract
Introduction: The aim of this study was to define the frequency and associated clinical phenotype of anti-MDA5 autoantibodies in a large UK based, predominantly Caucasian, cohort of patients with juvenile dermatomyositis (JDM). Methods: Serum samples and clinical data were obtained from 285 patients with JDM recruited to the UK Juvenile Dermatomyositis Cohort and Biomarker Study. The presence of anti-MDA5 antibodies was determined by immunoprecipitation and confirmed by ELISA using recombinant MDA5 protein. Results were compared with matched clinical data, muscle biopsies (scored by an experienced paediatric neuropathologist) and chest imaging (reviewed by an experienced paediatric radiologist). Results: Anti-MDA5 antibodies were identified in 7.4% of JDM patients and were associated with a distinct clinical phenotype including skin ulceration (P = 0.03) oral ulceration (P = 0.01), arthritis (P <0.01) and milder muscle disease both clinically (as determined by Childhood Myositis Assessment Score (P = 0.03)) and histologically (as determined by a lower JDM muscle biopsy score (P <0.01)) than patients who did not have anti-MDA5 antibodies. A greater proportion of children with anti-MDA5 autoantibodies achieved disease inactivity at two years post-diagnosis according to PRINTO criteria (P = 0.02). A total of 4 out of 21 children with anti-MDA5 had interstitial lung disease; none had rapidly progressive interstitial lung disease. Conclusions: Anti-MDA5 antibodies can be identified in a small but significant proportion of patients with JDM and identify a distinctive clinical sub-group. Screening for anti-MDA5 autoantibodies at diagnosis would be useful to guide further investigation for lung disease, inform on prognosis and potentially confirm the diagnosis, as subtle biopsy changes could otherwise be missed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Betteridge, Z., & McHugh, N. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12451 · Cited by 1,056
Self-citationMcHugh, N. J., & Tansley, S. L. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.56 · Cited by 390
Self-citationDermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Nombel, A., Fabien, N., & Coutant, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773352 · Cited by 262
Xue, Y., Zhang, J., Li, C., Liu, X., Kuang, W., Deng, J., Wang, J., Tan, X., Li, S., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940802 · Cited by 13
Metadata
- Authors
- Tansley, S. L., Betteridge, Z. E., Gunawardena, H., Jacques, T. S., Owens, C. M., Pilkington, C., Arnold, K., Yasin, S., Moraitis, E., Wedderburn, L. R., & McHugh, N. J.
- Venue
- Arthritis Research & Therapy
- Published
- 2014-07-02
- Volume
- 16
- Issue
- 4
- Pages
- R138-R138
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W2140059068
- Cited by
- 194
- References
- 0
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. https://app.cochat.ai/papers/10.1186/ar4600
- The paper
- Tansley, S. L., Betteridge, Z. E., Gunawardena, H., Jacques, T. S., Owens, C. M., Pilkington, C., Arnold, K., Yasin, S., Moraitis, E., Wedderburn, L. R., & McHugh, N. J. (2014). Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Research & Therapy. https://doi.org/10.1186/ar4600
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.